4-methyl-5-(2-hydroxyethyl)thiazole kinase (ThiK)

4-methyl-5-(2-hydroxyethyl)thiazole kinase (ThiK) is a critical enzyme in the de novo biosynthesis and salvage pathways of thiamine pyrophosphate (TPP), the active form of vitamin B1 [1, 2]. It catalyzes the ATP-dependent phosphorylation of 4-methyl-5-(2-hydroxyethyl)thiazole to form 4-methyl-5-(2-phosphoethyl)thiazole, which is subsequently coupled with a pyrimidine moiety to form thiamine [2, 3]. This enzyme is essential for the survival of many bacteria, fungi, and plants, as TPP serves as a vital cofactor for central metabolic enzymes like pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase [3, 4]. Importantly, the ThiK-mediated thiamine synthesis pathway is absent in humans, who must obtain vitamin B1 through their diet via specialized transporters [1, 5]. This fundamental biological difference makes ThiK an attractive target for the development of narrow-spectrum antimicrobial agents that can selectively starve pathogens of a necessary cofactor without affecting human metabolism [4, 5]. Current research focuses on identifying small-molecule inhibitors that mimic the thiazole substrate to disrupt bacterial growth, particularly in antibiotic-resistant strains [5].

Other names

Thiazole kinase4-methyl-5-beta-hydroxyethylthiazole kinaseTHZ kinaseHydroxyethylthiazole kinaseATP:4-methyl-5-(2-hydroxyethyl)thiazole 2-phosphotransferase

Inhibition of thiamine pyrophosphate (TPP) biosynthesis by competitive binding to the thiazole or ATP binding sites, leading to the depletion of essential metabolic cofactors in pathogens.